11 Nov 2021

CARBOWAX™ and CARBOWAX™ SENTRY™ Polyethylene Glycols (PEGs)

PDF 979 kB

CARBOWAX™ and CARBOWAX™ SENTRY™ Polyethylene Glycols (PEGs) are highly versatile excipients and active pharmaceutical ingredients (APIs) produced to meet the exacting requirements of the pharmaceutical industry

Content provided by our supplier


  • US
  • 2018
    On CPHI since
  • 5000+
Company types

Other Content from Dow (2)

  • News Dow announces new alkoxylation capacity in U.S. and Europe to meet continued robust demand growth

    New capacity to support global growth in key end-markets delivering 10% to 15% annual growth rates. This builds on previously announced capacity expansions, increasing the company's global alkoxylation capacity by 70% vs. 2020 baseline, collectively. Higher return and faster-payback projects expected to come online in 2024 and 2025. 
  • Video Reimagining How You Work with Your Excipient Supplier: Product Quality Beyond Compendial Requirements

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. One of the top priorities of pharmaceutical companies in bringing new products to market is to prove a drug substance is safe and effective against a certain illness. As you would expect, especially in the beginning stages of development, companies primarily focus on the API itself and not necessarily the excipients that will go into the final drug product. Instead, compendial requirements and guidelines such as those from ICH exist to ensure excipient quality and safety. Not only this is important from a regulatory perspective, but excipient quality can also impact product performance, even if those excipients meet all compendial requirements. In this session, you will learn about: Recent regulatory developments relating to residual impurities in pharmaceutical excipients Challenges in analytical methods to meet increasingly stringent targets How you can work with your excipient supplier to ensure high product quality